CYP4A11 and metabolic dysfunction-associated steatotic liver disease: Remarkably, CYP4A11 up-regulation has been associated with non-alcoholic fatty liver disease (NAFLD), since it increases the intracellular production of reactive oxygen species (ROS) and pro-inflammatory cytokines [72].